Epidemiology of Drug-Resistant Tuberculosis
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-64371-7_11
Reference64 articles.
1. Aia P, Kal M, Lavu E et al (2016) The burden of drug-resistant tuberculosis in Papua New Guinea: results of a large population-based survey. PLoS One 11:e0149806. doi: 10.1371/journal.pone.0149806
2. Almeida D, Rodrigues C, Ashavaid TF et al (2005) High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 40:881–886
3. Billington OJ, McHugh TD, Gillespie SH (1999) Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 43:1866–1869
4. Blower SM, Chou T (2004) Modeling the emergence of the “hot zones”: tuberculosis and the amplification dynamics of drug resistance. Nat Med 10:1111–1116
5. Borgdorff MW (2004) New measurable indicator for tuberculosis case detection. Emerg Infect Dis 10:1523–1528. doi: 10.3201/eid1009.040349
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12
2. The anti-tubercular callyaerins target the Mycobacterium tuberculosis-specific non-essential membrane protein Rv2113;Cell Chemical Biology;2024-07
3. Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis;Molecular Biology Reports;2023-11-16
4. The anti-tubercular callyaerins target theMycobacterium tuberculosis-specific non-essential membrane protein Rv2113;2023-07-12
5. Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis;PLOS ONE;2023-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3